Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Total Non-Current Liabilities: 2015-2025

Historic Total Non-Current Liabilities for BIO-TECHNE (TECH) over the last 11 years, with Jun 2025 value amounting to $612.0 million.

  • BIO-TECHNE's Total Non-Current Liabilities fell 7.11% to $536.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $536.5 million, marking a year-over-year decrease of 7.11%. This contributed to the annual value of $612.0 million for FY2025, which is 1.59% down from last year.
  • As of FY2025, BIO-TECHNE's Total Non-Current Liabilities stood at $612.0 million, which was down 1.59% from $621.9 million recorded in FY2024.
  • BIO-TECHNE's Total Non-Current Liabilities' 5-year high stood at $666.3 million during FY2021, with a 5-year trough of $581.6 million in FY2022.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $621.9 million (2024), whereas its average is $631.7 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first declined by 12.72% in 2022, then rose by 13.70% in 2023.
  • Over the past 5 years, BIO-TECHNE's Total Non-Current Liabilities (Yearly) stood at $666.3 million in 2021, then dropped by 12.72% to $581.6 million in 2022, then grew by 13.70% to $661.3 million in 2023, then fell by 5.96% to $621.9 million in 2024, then fell by 1.59% to $612.0 million in 2025.